Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation. - Wikidata - awgldk - TriplyDB

Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.

Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.

http://www.wikidata.org/entity/Q38552040

about

Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases GADD34 Keeps the mTOR Pathway Inactivated in Endoplasmic Reticulum Stress Related Autophagy.p53 coordinates decidual sestrin 2/AMPK/mTORC1 signaling to govern parturition timing.Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor.Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer.Resveratrol protects against L-arginine-induced acute necrotizing pancreatitis in mice by enhancing SIRT1-mediated deacetylation of p53 and heat shock factor 1.Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches.Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells.Introduction to Resveratrol and Health: 3rd International Conference.Aberrant SIRT6 expression contributes to melanoma growth: Role of the autophagy paradox and IGF-AKT signaling.Resveratrol in the foodomics era: 1:25,000.[Advances in the Research of the Regulation of Chinese Traditional Medicine Monomer and Its Derivatives on Autophagy in Non-small Cell Lung Cancer].The therapeutic potential of resveratrol: a review of clinical trials.

P2860

Q28069705-B418C398-0B57-41A4-A688-7F992C531884 Q36228566-EEC9095F-032A-4FE1-A345-E49003A1C0F2 Q37137927-520D342E-EAEE-43B9-A45A-FC2B2B205201 Q37715501-2867C6A5-43EB-423A-9574-C6B030FA1581 Q38735342-BAB9875A-D65A-44D9-8138-8E38452A5331 Q38741051-33497747-F345-457B-B6F6-7E17CE820A96 Q38994919-01C8041B-8995-42E5-9B3B-AFB995A5D360 Q39336887-D8ED6677-7092-4DA6-A44D-9FCF043AC58C Q48954253-E7EEF134-9830-48D8-BB24-830B37375765 Q50035013-21AFEA80-317D-4131-BF11-EFC1A3ADEB0D Q50197781-6739218C-7B40-40AD-93A4-4483839D20A4 Q53427956-380E82C1-E507-4405-AFB4-CB04AD835ED0 Q55151370-5E465B2F-CF79-4720-B9E1-50C6FC5C5355

P2860

Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.

http://www.wikidata.org/entity/Q38552040

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.

@en

type

label

Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.

@en

prefLabel

Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.

@en

P1433

Q38552040-CB70107C-2829-47DB-9E65-13360306A493

P1476

Q38552040-496B7DAD-F6CC-4E03-9C57-FE6EE11C6156

P2093

Q38552040-2647C4D4-74E3-46EC-B08C-89BA4FFF3A0B

Q38552040-4BAD638C-B178-4A7D-AE8C-2791DA46C762

Q38552040-D472F00B-8794-4D0A-BAEE-A96DC1CB7071

P2860

Q38552040-01C9B5AC-8002-4786-AB01-CFE06708E3BD

Q38552040-09C26E49-1D60-48DF-B979-73C3B1E8CFF4

Q38552040-144723D1-79E4-4408-BCE5-E4BD56F957B3

Q38552040-1489F19F-1EAD-44F2-B0ED-EA66499E1070

Q38552040-18C30DF3-09D6-4715-8F18-BE038E6586B7

Q38552040-1BCDA414-C868-432C-9011-8C267EC37BD7

Q38552040-1C9D545B-C146-45B8-9008-7922E9BF6E62

Q38552040-217578AA-F8EE-4076-9146-160574353787

Q38552040-25A95620-CDF4-4FC5-AD1F-5CE0FD2BC95E

Q38552040-272D6065-B2D5-43F3-A737-BCCAE4644EFB

P304

Q38552040-7208569C-DC83-4588-B2C5-08CA4331C3B5

P31

Q38552040-B515703B-C6EA-424D-ACCF-54543ECAE13F

P356

Q38552040-41D2669C-26F9-4908-B1B9-E9AB6FF29F15

P407

Q38552040-D37763E5-5F73-4D20-A2AD-1BE733BCD543

P433

Q38552040-DCD89296-28C1-4821-A9ED-B579EE479A4D

P478

Q38552040-123399E3-4B7A-44F3-BF51-3C2137D0B22B

P577

Q38552040-725D4556-8556-4276-B274-392AA2190177

P698

Q38552040-73FC18C2-5B5E-49C1-9C6F-D1E320DBB549

P356

P1433

Annals of the New York Academy of Sciences

P1476

Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.

@en

P2093

Anya Alayev

http://www.w3.org/2001/XMLSchema#string

Marina K Holz

http://www.w3.org/2001/XMLSchema#string

Sara Malka Berger

http://www.w3.org/2001/XMLSchema#string

P2860

SIRT1 negatively regulates the mammalian target of rapamycin

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival

AMPK phosphorylation of raptor mediates a metabolic checkpoint

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer

Resveratrol improves health and survival of mice on a high-calorie diet

Induction of autophagy and inhibition of tumorigenesis by beclin 1

P304

116-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/NYAS.12829

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1348

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26200935

http://www.w3.org/2001/XMLSchema#string